Company Performance Metrics
Macheon AI is redefining surgical robotics by commercializing a clinically validated platform developed at Johns Hopkins University by Dr. Russell Taylor’s LCSR group. Our intelligent robotic assistant is designed for high-risk, underserved procedures in skull base, spine, and otolaryngology. Backed by published research, cadaver validation, and
initial FDA clearance, Macheon is positioned to lead the next era of precision surgery. With a software-first architecture, real-time AI, and micro-robotic fidelity, we offer investors a rare opportunity: to back a mature, de-risked platform ready for first-in-human trials and accelerated market entry. We are raising a $6M seed round to fuel clinical deployment and scale our commercialization efforts.
